Erratum: Glioma grading: Sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging (Journal of Neuro-Oncology (2009) 94 (87-96) DOI 10.1007/s11060-009-9807-6);Glioma grading: Sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging

Journal of Neuro-Oncology

Volumn 94, Issue 1, 2009, Pages 87-96

  Arvinda, H R ^a   Kesavadas, C ^a   Sarma, P S ^a   Thomas, B ^a   Radhakrishnan, V V ^a   Gupta, A K ^a   Kapilamoorthy, T R ^a   Nair, S ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Diffusion; Glioma; Grading; MRI; Perfusion

Indexed keywords

ACCURACY; ADULT; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; CANCER GRADING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOMA; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PERFUSION WEIGHTED IMAGING; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 67650459914     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1205-4     Document Type: Erratum

References (57)

1. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P (1988) Grading of astrocytomas: A simple and reproducible method. Cancer 62:2152-2165. doi: 10.1002/ 1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO;2-T
2. Law M, Yang S, Babb JS, Edmond A et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 25:746-755
3. Rees J (2003) Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 16:643-650. doi: 10.1097/00019052-200312000-00001
4. Christoforidis GA, Grecula JC, Newton HB et al (2002) Visualization of microvascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. Am J Neuroradiol 23:1553-1556
5. Brant-Zawadzki M, Berry I, Osaki L et al (1986) Gd-DTPA in clinical MR of the brain: I. Intraaxial lesions. Am J Roentgenol 147:1223-1230
6. Brant-Zawadzki M, Badami JP, Mills CM et al (1984) Primary intracranial tumor imaging: A comparison of magnetic resonance and CT. Radiology 150:435-440
7. Bydder GM, Steiner RE, Young IR et al (1982) Clinical NMR imaging of the brain: 140 cases. Am J Roentgenol 139:215-236
8. Just M, Thelen M (1988) Tissue characterization with T1, T2, and proton density values: Results in 160 patients with brain tumors. Radiology 169:779-785
9. Felix R, Schorner W, Laniado M et al (1985) Brain tumors MR imaging with gadolinium-DTPA. Radiology 156:681-688
10. Moller-Hartmann W, Herminghaus S, Krings T et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381. doi: 10.1007/ s00234-001-0760-0
11. Dean BL, Drayer BP, Bird CR et al (1990) Gliomas classification with MR imaging. Radiology 174:411-415
12. Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34:463-469. doi: 10.1007/BF00598951
13. Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533-536
14. Knopp EA, Cha S, Johnson G et al (1999) Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211:791-798
15. Kurki T, Lundbom N, Kalimo H, Valtonen S (1995) MR classification of brain gliomas: Value of magnetization transfer and conventional imaging. Magn Reson Imaging 13:501-511. doi: 10.1016/0730-725X(95)00006-3
16. Mihara F, Numaguchi Y, Rothman M, Kristt D, Fiandaca M, Swallow L (1995) Non-enhancing supratentorial malignant astrocytomas: MR features and possible mechanisms. Radiat Med 13:11-17
17. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947-949
18. Burger PC, Vogel FS, Green SB et al (1985) Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications. Cancer 56:1106-1111. doi: 10.1002/ 1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2
19. Burger P (1986) Malignant astrocytic neoplasms: Classification, pathology, anatomy, and response to therapy. Semin Oncol 13:16-20
20. Petrella JR, Provenzale JM (2000) MR perfusion imaging of the brain: techniques and applications. Am J Roentgenol 175:207-219
21. Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 191:41-51
22. Bruening R, Kwong KK, Vevea MJ et al (1996) Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. Am J Neuroradiol 17:831-840
23. Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 171:1479-1486
24. Sugahara T, Korogi Y, Shigematsu Y et al (1999) Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging 10:114-124. doi: 10.1097/ 00002142-199904000-00004
25. Wong ET, Jackson EF, Hess KR et al (1998) Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 50:777-781
26. Wong JC, Provenzale JM, Petrella JR (2000) Perfusion MR imaging of brain neoplasms. Am J Roentgenol 174:1147-1157
27. Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29. doi: 10.1148/radiol.2231010594
28. Lev MH, Rosen BR (1999) Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 9:309-331
29. Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 179:783-789
30. Chenevert TL, McKeever PE, Ross BD (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 3:1457-1466
31. Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F (1997) MR diffusion imaging of human intracranial tumours. Neuroradiology 39:483-489. doi: 10.1007/s002340050450
32. Filippi CG, Edgar MA, Ulug AM, Prowda JC, Heier LA, Zimmerman RD (2001) Appearance of meningiomas on diffusion-weighted images: Correlating diffusion constants with histopathologic findings. Am J Neuroradiol 22:65-72
33. Stadnik TW, Chaskis C, Michotte A et al (2001) Diffusion-weighted MR imaging of intracerebral masses: Comparison with conventional MR imaging and histologic findings. Am J Neuroradiol 22:969-976
34. Eis M, Els T, Hoehn-Berlage M, Hossmann KA (1994) Quantitative diffusion MR imaging of cerebral tumor and edema. Acta Neurochir Suppl (Wien) 60:344-346
35. Eis M, Els T, Hoehn-Berlage M (1995) High resolution quantitative relaxation and diffusion MRI on three different experimental brain tumors in rat. Magn Reson Med 34:835-844. doi: 10.1002/mrm.1910340608
36. Els T, Eis M, Hoehn-Berlage M, Hossmann KA (1995) Diffusion-weighted MR imaging of experimental brain tumors in rats. MAGMA 3:13-20. doi: 10.1007/BF02426396
37. Gupta RK, Sinha U, Cloughesy TF, Alger JR (1999) Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 41:2-7. doi: 10.1002/(SICI)1522-2594(199901)41:1<2::AID-MRM2>3.0.CO;2-Y
38. Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53-60. doi: 10.1002/ (SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2
39. Gupta RK, Cloughesy TF, Sinha U et al (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215-226. doi: 10.1023/A:1006431120031
40. Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60-64
41. Gauvain KM, McKinstry RC, Mukherjee P et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 177:449-454
42. Nonomura Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757-760. doi: 10.1002/jmri.1105
43. Kono K, Inoue Y, Nakayama K et al (2001) The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 22:1081-1088
44. Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and high-grade astrocytomas: Comparison of water diffusibility and histologic characteristics. Radiology 224:177-183. doi: 10.1148/ radiol.2241010637
45. Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J (1994) MR imaging of high-grade cerebral gliomas: Value of diffusion-weighted echoplanar pulse sequences. Am J Roentgenol 162:671-677
46. Fan G, Zang P, Jing F, Wu Z, Guo Q (2005) Usefulness of diffusion/ perfusion-weighted MRI in rat gliomas: Correlation with histopathology. Acad Radiol 12:640-651. doi: 10.1016/j.acra.2005.01.024
47. Fan G, Deng QL, Wu ZH et al (2006) Usefulness of diffusion/ perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: A valuable tool to predict tumour grading? Br J Radiol 79:652-658. doi: 10.1259/bjr/25349497
48. Catalaa I, Henry R, Dillon WP, Graves EE et al (2006) Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 19(4):463-475. doi: 10.1002/nbm.1059
49. Ringertz J (1950) Grading of gliomas. Acta Pathol Microbiol Scand 27:51-64
50. Batra A, Tripathi RP, Singh AK (2004) Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging. Australas Radiol 48:324-332. doi: 10.1111/ j.0004-8461.2004.01315.x
51. Maia AC Jr, Malheiros SM, da Rocha AJ et al (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol 26:777-783
52. Peters AM (1998) Fundamentals of tracer kinetics for radiologists. Br J Radiol 71:1116-1129
53. Guyton AC (1991) Cerebral blood flow, the cerebrospinal fluid, and brain metabolism. Basic neuroscience: Anatomy and physiology, 2nd edn. Saunders, Philadelphia, pp 285-287
54. Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: Correlation with histologic grade. Am J Neuroradiol 21:891-899
55. Law M, Yang S et al (2003) Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 24:1989-1998
56. Lev MH, Ozsunar Y, Henson JW et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: Confounding effect of elevated rCBV of oligodendrogliomas. Am J Neuroradiol 25:214-221. Corrected, published erratum appears in Am J Neuroradiol 2004;25:B1
57. Bulakbasi N, Kocaoglu M, Örs F (2003) Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. Am J Neuroradiol 24:225-233